resources

Parnax Lab Ltd.

BSE: 506128

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

139.00-2.4 (-1.70%)

24 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Parnax Lab Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Parnax Lab Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201123 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mihir Shah, Baiju Shah, Prakash Shah, Ila B Shah
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201123 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Baiju Shah
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201123 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ila B Shah
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201122 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mihir Shah
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201122 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakash Mahasukhlal Shah
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the Confirmation Certificate under Regulation 74(5) from RTA for the Quarter Ended June 30, 2026.
Newspaper Publication9 Jul 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the Newspaper Publication regarding confirming dispatch of Postal Ballot Notice.
Postal Ballot8 Jul 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find enclosed herewith the Postal Ballot Notice for seeking approval of Shareholders of the company w.r.t. the Re-appointment of Mr. Yogesh Kantilal Varia (DIN: 09186184) as a Non-Executive ....
Closure of Trading Window29 Jun 2026
Closure of Trading Window
Please find enclosed herewith the Closure of Trading Window Intimation for the Quarter and Three Months Ended June, 2026.
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 201127 Jun 2026
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 201127 Jun 2026
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
Reg.24(A)-Annual Secretarial Compliance30 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed herewith the Annual Secretarial Compliance Report under reg. 24(A) for the Year ended March, 2026.
Change in Management28 May 2026
Announcement under Regulation 30 (LODR)-Change in Management
Please find enclosed herewith the Intimation regarding the Re-appointment of Mr. Yogesh K. Varia as an Independent Director of the Company, for a second term of 5 consecutive years w.e.f. ....
Outcome of Board Meeting28 May 2026
Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Standalone & Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended 31St March, 2026, Along With Auditor'S Report Thereon.
Board Meeting Outcome for Consideration and Approval of Standalone & Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2026, along with Auditor's ....
Board Meeting20 May 2026
Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Audited IND- AS Compliant Financial Results Along With Auditor Report For The Quarter (Q4) And Year Ended 31St March, 2026
Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Standalone and Consolidated Audited ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Apr 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith the Compliance Certificate under regulation 74(5) of SEBI (DP) Regulation, 2018.
Closure of Trading Window27 Mar 2026
Closure of Trading Window
The Trading Window for dealing in securities will be closed for all the Insiders, Designated Persons, and their Immediate Relatives w.e.f. 01st April, 2026 and shall open 48 hours after ....
Outcome of Board Meeting13 Feb 2026
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting for Considered and Approved the Standalone & Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025
Board Meeting5 Feb 2026
Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited Financial Results Along With Limited Review Report For The Quarter (Q3) And Nine Months Ended 31St December, 2025.
Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Standalone and Consolidated Un-audited ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201822 Jan 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018 for quarter ended 31st December, 2025

Frequently Asked Questions

Where can I download the annual report of Parnax Lab Ltd.?

Annual reports of Parnax Lab Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Parnax Lab Ltd.?

Quarterly earnings results and presentations of Parnax Lab Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Parnax Lab Ltd. publish earnings call transcripts?

Earnings call transcripts of Parnax Lab Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Parnax Lab Ltd.?

Investor presentations and annual day presentations of Parnax Lab Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Parnax Lab Ltd.?

Corporate announcements and regulatory filings of Parnax Lab Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Parnax Lab Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Parnax Lab Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Parnax Lab Ltd.?

The ISIN (International Securities Identification Number) of Parnax Lab Ltd. is INE383L01019. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Parnax Lab Ltd. listed?

Parnax Lab Ltd. is listed on NSE and BSE. The NSE symbol is PARNAXLAB and the BSE code is -.

Where can I find the shareholding pattern of Parnax Lab Ltd.?

The quarterly shareholding pattern of Parnax Lab Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Parnax Lab Ltd. on Sharpely?

Share price data for Parnax Lab Ltd. is updated as of 24 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.